Naloxone Aids Out-of-Hospital Cardiac Arrest Outcomes, Regardless of Drug Use
By Lori Solomon HealthDay Reporter
THURSDAY, Aug. 29, 2024 -- Regardless of drug use, administration of naloxone during out-of-hospital cardiac arrest (OHCA) is associated with improved outcomes, such as increased survival to hospital discharge, according to a study published online Aug. 20 in JAMA Network Open.
David G. Dillon, M.D., Ph.D., from the University of California, Davis, and colleagues used data from 8,195 patients with OHCA treated by five emergency medical service agencies in three Northern California counties (2015 to 2023) to determine whether naloxone administration during OHCA is associated with return of spontaneous circulation (ROSC) or survival to hospital discharge.
The researchers found that naloxone was administered to 14.2 percent of patients and was associated with increased ROSC using both nearest-neighbor propensity matching (absolute risk difference [ARD], 15.2 percent) and inverse propensity-weighted regression adjustment (ARD, 11.8 percent). There was also an association between naloxone administration and increased survival to hospital discharge using both nearest-neighbor propensity matching (ARD, 6.2 percent) and inverse propensity-weighted regression adjustment (ARD, 3.9 percent). For ROSC, the number needed to treat with naloxone was nine, and for survival to hospital discharge, it was 26. Naloxone was associated with improved survival to hospital discharge in both those with presumed drug-related OHCA (odds ratio, 2.48) and non-drug-related OHCA groups (odds ratio, 1.35).
"These findings support further evaluation of naloxone as part of cardiac arrest care," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Cardiorespiratory Effects of Smoke Fine Particulate Matter From Wildfires Can Persist for Months
THURSDAY, June 5, 2025 -- The cardiorespiratory effects of smoke fine particulate matter (PM2.5), a primary wildfire emission that can spike for months after a wildfire begins...
Cardiometabolic Risk Factors Account for More Than One-Third of Dementia Risk
THURSDAY, June 5, 2025 -- A substantial number of U.S. dementia cases could be eliminated by mitigating modifiable cardiometabolic risk factors, according to a study published...
Cardiac Deaths Remain Elevated Since 2020
WEDNESDAY, June 4, 2025 -- Cardiac deaths increased substantially starting in 2020, according to a research letter published online May 30 in JAMA Network Open. Jason H. Wasfy...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.